Wirksamkeit und Therapiesicherheit von Tofacitinib in der Behandlung der mittelschweren und schweren Colitis ulcerosa sowie potentielle Prädiktoren eines Ansprechens: eine multizentrische Auswertung

Autor: AM Globig, W Reindl, P Hasselblatt, Annika Gauss, A Thomann, Peter Hoffmann

Publikováno v: DGVS Digital: BEST OF DGVS.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f87adcdf80ff0298ce5295960f1440f8
https://doi.org/10.1055/s-0040-1716143

Ustekinumab-Serumspiegel sind mit klinischem Ansprechen korreliert – Real-World-Daten einer regionalen multizentrischen Untersuchung an Patienten mit M. Crohn

Autor: AK Thomann, J Klaus, Peter Hoffmann, LA Schulte, T Klag, W Reindl, T Itzel, Matthias P. Ebert, A Teufel, N Scheffe, AM Globig, R Schreiner, J Wehkamp, P Hasselblatt, Annika Gauss

Publikováno v: Zeitschrift für Gastroenterologie.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8d93a46af829db03f4b7270a376b2de2
https://doi.org/10.1055/s-0039-1695152

P181 Cytomegalovirus infections are rare in hospitalised patients with flares of inflammatory bowel disease—a monocentre retrospective cohort study

Autor: C Monasterio, L-V Lorenz, Peter Hasselblatt, AM Globig

Publikováno v: Journal of Crohn's and Colitis. 13:S180-S181

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51809cff3df387da5a67f4a33e02a493
https://doi.org/10.1093/ecco-jcc/jjy222.305

P084 Clinical response to Ustekinumab in Crohn’s disease is linked to a dose-dependent reduction of T follicular helper cells

Autor: Christoph M. Schempp, N P Sommer, Anne K. Thomann, R Schreiner, Robert Thimme, Maike Hofmann, W Reindl, AM Globig, Peter Hasselblatt

Publikováno v: Journal of Crohn's and Colitis. 13:S127-S127

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d44cd488847f6c4b95ea23df0ead570b
https://doi.org/10.1093/ecco-jcc/jjy222.208

EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth.

Autor: Kuhlmann-Hogan A; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut.; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, California., Cordes T; Molecular and Cellular Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California.; Department of Bioinformatics and Biochemistry, Braunshweig Integrated Centre of Systems Biology (BRICS), Technishe Universität Braunschweig, Germany.; Research Group Cellular Metabolism in Infection, Helmholtz Centre for Infection Research, Braunschweig, Germany., Xu Z; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, California.; Division of Biological Sciences, University of California San Diego, La Jolla, California., Kuna RS; Molecular and Cellular Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California., Traina KA; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, California., Robles-Oteíza C; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut., Ayeni D; Departments of Pathology and Internal Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, Connecticut., Kwong EM; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California.; Sanford Consortium for Regenerative Medicine, La Jolla, California., Levy S; Departments of Pathology and Internal Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, Connecticut., Globig AM; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, California., Nobari MM; Division of Pulmonary and Critical Sleep Medicine, University of California San Diego, Department of Medicine, La Jolla, California., Cheng GZ; Division of Pulmonary and Critical Sleep Medicine, University of California San Diego, Department of Medicine, La Jolla, California., Leibel SL; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California.; Sanford Consortium for Regenerative Medicine, La Jolla, California., Homer RJ; Departments of Pathology and Internal Medicine (Section of Pulmonary, Critical Care and Sleep Medicine), Yale University School of Medicine, New Haven, Connecticut., Shaw RJ; Molecular and Cellular Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California., Metallo CM; Molecular and Cellular Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California., Politi K; Departments of Pathology and Internal Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, Connecticut.; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Kaech SM; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, California.

Publikováno v: Cancer discovery [Cancer Discov] 2024 Jan 25, pp. OF1-OF22. Date of Electronic Publication: 2024 Jan 25.